FLT3 is a receptor tyrosine kinase expressed in both AML and B-ALL, with low expression on myeloid dendritic cells and HSCs, which functions as a proto-oncogene playing a key role in promoting leukemic cell proliferation and survival, and expression is preserved in AML after relapse. Here, NTRK1 is linked to acute myeloid leukemia.